Koers Vitality Biopharma, Inc. Other OTC
Aandelen
VBIO
US92849B1070
Milieudiensten & -uitrusting
Omzet 2022 | 4,83 mln. 4,49 mln. | Omzet 2023 | 19,35 mln. 17,98 mln. | Marktkapitalisatie | 27,28 mln. 25,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -929K | Nettowinst (verlies) 2023 | 3 mln. 2,79 mln. | EV/omzet 2022 | 3,86 x |
Nettoschuld 2022 | 4,61 mln. 4,29 mln. | Nettoschuld 2023 | 8,23 mln. 7,65 mln. | EV/omzet 2023 | 1,84 x |
K/w-verhouding 2022 |
-11,4
x | K/w-verhouding 2023 |
7,17
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 53,01% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 50 | 15-11-18 | |
Patricia Missal
DFI | Director of Finance/CFO | 55 | 01-06-23 |
Rebecca Wharton
HRO | Human Resources Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward Feighan
CHM | Chairman | 76 | 15-11-18 |
Chief Executive Officer | 50 | 15-11-18 | |
Richard Celeste
BRD | Director/Board Member | 86 | 24-01-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,09% | 83,38 mld. | |
+12,47% | 58,42 mld. | |
+18,82% | 11,18 mld. | |
+24,45% | 11,11 mld. | |
-7,97% | 6,29 mld. | |
+27,47% | 4,92 mld. | |
+13,71% | 4,61 mld. | |
-5,29% | 3 mld. | |
-1,80% | 2,45 mld. |